We advised Auna on the offering

Davis Polk advised Auna, S.A. in connection with an offering of $365 million aggregate principal amount of 8.750% senior secured notes due 2032 co-issued by Auna and Oncosalud S.A.C, which includes $328.5 million issued pursuant to Rule 144A / Regulation S under the U.S. Securities Act of 1933 and $36.5 million issued in a concurrent private placement to International Finance Corporation in accordance with Section 4(a)(2) of the Securities Act. The notes are guaranteed on a senior secured basis by certain of Auna’s subsidiaries.

Davis Polk also advised Auna in connection with its concurrent cash tender offer and consent solicitation for any and all of its outstanding 10.000% senior secured notes due 2029. The concurrent cash tender offer was funded with proceeds from the notes offering.

Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. As of June 30, 2025, Auna’s network included 31 healthcare facilities –hospitals, ambulatory centers and prevention and wellness centers – with a total of 2,333 beds and 1.4 million health plan members.

The Davis Polk corporate team included partner Maurice Blanco and associate Marcos Sauquet Trias. The finance team included counsel James Vickers and associate José Miguel Fernández Mejía. Partner Ethan R. Goldman, counsel Liang Zhang and associate Valentin Van de Walle provided tax advice. Associates Caleb Beavers and Gianmarco Dedós Capote provided 1940 Act advice. Counsel Andrew H. Braid provided executive compensation advice. Members of the Davis Polk team are based in the New York and São Paulo offices.

Copy link to share post